Pfizer and its partner BioNTech asked U.S. regulators Tuesday to authorize an additional booster dose of their COVID-19 vaccine for seniors, saying data from Israel suggests older adults would benefit.
Mar 15, 2022
0
3
It's now two years since the World Health Organization began calling the COVID-19 outbreak a pandemic.
Mar 14, 2022
0
3
For adolescents aged 12 to 17 years, reactions to homologous Pfizer-BioNTech booster vaccination occur with similar frequency as after receipt of the second vaccine dose, and they are generally mild to moderate in severity, ...
Mar 4, 2022
0
2
Pfizer's new COVID-19 treatment came with a catch when it debuted late last year: Supplies were limited, and it can take months to make the tablets.
Mar 2, 2022
0
3
All testing and quarantine requirements for travelers to European Union member nations should be lifted next month for those who are vaccinated or have recovered from COVID-19, the European Council said Tuesday.
Feb 23, 2022
0
2
Australian children aged 6 to 11 years old will be able to get the Moderna COVID vaccine at pharmacies, GP clinics and vaccination hubs from tomorrow.
Feb 23, 2022
0
4
(HealthDay)—After you have recovered from COVID-19, getting at least one dose of a vaccine provides added protection against reinfection, Israeli researchers report.
Feb 17, 2022
2
101
(HealthDay)—The U.S. Food and Drug Administration announced Friday that it will postpone an advisory panel meeting that was slated for next week to weigh Pfizer's COVID vaccine for use in young children.
Feb 14, 2022
0
6
COVID-19 vaccinations for children under 5 hit another monthslong delay Friday as U.S. regulators abruptly put the brakes on their efforts to speed review of the shots that Pfizer is testing for youngsters.
Feb 11, 2022
0
8
Japan has granted fast-track approval to U.S. drug maker Pfizer Inc.'s COVID-19 pill, the heath minister said Thursday, as the country struggles to slow fast-spreading omicron infections.
Feb 10, 2022
0
2
